- Home
- MLTX vs MAX Comparison
MLTX vs MAX Comparison
Compare MLTX & MAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLTX
- MAX
- Stock Information
- Founded
- MLTX 2021
- MAX 2014
- Country
- MLTX Switzerland
- MAX United States
- Employees
- MLTX N/A
- MAX N/A
- Industry
- MLTX Biotechnology: Pharmaceutical Preparations
- MAX Industrial Machinery/Components
- Sector
- MLTX Health Care
- MAX Industrials
- Exchange
- MLTX Nasdaq
- MAX Nasdaq
- Market Cap
- MLTX 595.6M
- MAX 551.1M
- IPO Year
- MLTX N/A
- MAX 2020
- Fundamental
- Price
- MLTX $9.82
- MAX $11.47
- Analyst Decision
- MLTX Buy
- MAX Buy
- Analyst Count
- MLTX 9
- MAX 6
- Target Price
- MLTX $37.63
- MAX $18.17
- AVG Volume (30 Days)
- MLTX 12.2M
- MAX 463.4K
- Earning Date
- MLTX 11-07-2025
- MAX 10-29-2025
- Dividend Yield
- MLTX N/A
- MAX N/A
- EPS Growth
- MLTX N/A
- MAX N/A
- EPS
- MLTX N/A
- MAX N/A
- Revenue
- MLTX N/A
- MAX $1,075,712,000.00
- Revenue This Year
- MLTX N/A
- MAX $27.56
- Revenue Next Year
- MLTX N/A
- MAX $10.79
- P/E Ratio
- MLTX N/A
- MAX N/A
- Revenue Growth
- MLTX N/A
- MAX 116.58
- 52 Week Low
- MLTX $5.95
- MAX $7.33
- 52 Week High
- MLTX $62.75
- MAX $20.91
- Technical
- Relative Strength Index (RSI)
- MLTX 27.40
- MAX 54.89
- Support Level
- MLTX $8.92
- MAX $10.49
- Resistance Level
- MLTX $9.47
- MAX $11.18
- Average True Range (ATR)
- MLTX 0.62
- MAX 0.43
- MACD
- MLTX 1.54
- MAX 0.05
- Stochastic Oscillator
- MLTX 47.44
- MAX 88.00
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.
About MAX MediaAlpha Inc.
MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.